Zhu Chen
About
In The Last Decade
Zhu Chen
16 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Molecular Biology 2.1k
- Hematology 1.0k
- Biochemistry 448
- Oncology 224
- Genetics 222
Countries citing papers authored by Zhu Chen
This map shows the geographic impact of Zhu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhu Chen more than expected).
Fields of papers citing papers by Zhu Chen
This network shows the impact of papers produced by Zhu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhu Chen. The network helps show where Zhu Chen may publish in the future.
Co-authorship network of co-authors of Zhu Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Zhu Chen. A scholar is included among the top collaborators of Zhu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhu Chen. Zhu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 2 | |
| 7 | 38 | |
| 8 | 39 | |
| 9 | 9 | |
| 10 | 16 | |
| 11 | CCL2-CCL5/CCR4 contributed to radiation-induced epithelial-mesenchymal transition of HPAEpiC cells via the ERK signaling pathways. | 16 |
| 12 | 4 | |
| 13 | 129 | |
| 14 | Acute promyelocytic leukemia: from highly fatal to highly curable breakdown → | 916 |
| 15 | 14 | |
| 16 | Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients breakdown → | 1181 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.